Development and Characterization of a Humanized Anti-HER2 Antibody HuA21 with Potent Anti-Tumor Properties in Breast Cancer Cells

By Li Ruilin   Hu Siyi   Chang Yan   Zhang Zhihui   Zha Zhao   Huang Hui   Shen Guodong   Liu Jing   Song Lihua   Wei Wei  

International Journal of Molecular Sciences, Vol. 17, Iss. 4, 2016-04 ,pp. : 563-563

MDPI

Access to resources Recommend Favorite

HER2-Targeted Multifunctional Silica Nanoparticles Specifically Enhance the Radiosensitivity of HER2-Overexpressing Breast Cancer Cells

By Yamaguchi Haruka   Hayama Kazuhide   Sasagawa Ichiro   Okada Yasuo   Kawase Tomoyuki   Tsubokawa Norio   Tsuchimochi Makoto  

International Journal of Molecular Sciences, Vol. 19, Iss. 3, 2018-03 ,pp. : 908-908

MDPI

Access to resources Recommend Favorite

A Conjugate Based on Anti-HER2 Diaffibody and Auristatin E Targets HER2-Positive Cancer Cells

By Serwotka-Suszczak Anna M.   Sochaj-Gregorczyk Alicja M.   Pieczykolan Jerzy   Krowarsch Daniel   Jelen Filip   Otlewski Jacek  

International Journal of Molecular Sciences, Vol. 18, Iss. 2, 2017-02 ,pp. : 401-401

MDPI

Access to resources Recommend Favorite

Breast cancer stem cells are involved in Trastuzumab resistance through the HER2 modulation in 3D culture

By  

JOURNAL OF CELLULAR BIOCHEMISTRY, Vol. 119, Iss. 2, 2018-02 ,pp. : 1381-1391

John Wiley & Sons Inc

Access to resources Recommend Favorite

HER-2 Expression in Brain Metastases from Colorectal Cancer and Corresponding Primary Tumors: A Case Cohort Series

By Aprile Giuseppe   De Maglio Giovanna   Menis Jessica   Casagrande Mariaelena   Tuniz Francesco   Pisa Federica Edith   Fontanella Caterina   Skrap Miran   Beltrami Carlo Alberto   Fasola Gianpiero   Pizzolitto Stefano  

International Journal of Molecular Sciences, Vol. 14, Iss. 2, 2013-01 ,pp. : 2370-2387

MDPI

Access to resources Recommend Favorite